• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变构抑制通过构象集合对不同“混合”状态的采样来解释。

Allosteric inhibition explained through conformational ensembles sampling distinct "mixed" states.

作者信息

Byun Jung Ah, VanSchouwen Bryan, Akimoto Madoka, Melacini Giuseppe

机构信息

Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.

Department of Chemistry and Chemical Biology, McMaster University, Hamilton, Ontario, Canada.

出版信息

Comput Struct Biotechnol J. 2020 Nov 11;18:3803-3818. doi: 10.1016/j.csbj.2020.10.026. eCollection 2020.

DOI:10.1016/j.csbj.2020.10.026
PMID:33335680
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7720024/
Abstract

Allosteric modulation provides an effective avenue for selective and potent enzyme inhibition. Here, we summarize and critically discuss recent advances on the mechanisms of allosteric partial agonists for three representative signalling enzymes activated by cyclic nucleotides: the cAMP-dependent protein kinase (PKA), the cGMP-dependent protein kinase (PKG), and the exchange protein activated by cAMP (EPAC). The comparative analysis of partial agonism in PKA, PKG and EPAC reveals a common emerging theme, the sampling of distinct "mixed" conformational states, either within a single domain or between distinct domains. Here, we show how such "mixed" states play a crucial role in explaining the observed functional response, partial agonism and allosteric pluripotency, as well as in maximizing inhibition while minimizing potency losses. In addition, by combining Nuclear Magnetic Resonance (NMR), Molecular Dynamics (MD) simulations and Ensemble Allosteric Modeling (EAM), we also show how to map the free-energy landscape of conformational ensembles containing "mixed" states. By discussing selected case studies, we illustrate how MD simulations and EAM complement NMR to quantitatively relate protein dynamics to function. The resulting NMR- and MD-based EAMs are anticipated to inform not only the design of new generations of highly selective allosteric inhibitors, but also the choice of multidrug combinations.

摘要

变构调节为选择性和强效酶抑制提供了一条有效途径。在此,我们总结并批判性地讨论了环核苷酸激活的三种代表性信号酶变构部分激动剂机制的最新进展:环磷酸腺苷(cAMP)依赖性蛋白激酶(PKA)、环磷酸鸟苷(cGMP)依赖性蛋白激酶(PKG)以及cAMP激活的交换蛋白(EPAC)。对PKA、PKG和EPAC中部分激动作用的比较分析揭示了一个共同的新主题,即在单个结构域内或不同结构域之间对不同的“混合”构象状态进行抽样。在此,我们展示了这种“混合”状态如何在解释观察到的功能反应、部分激动作用和变构多能性方面发挥关键作用,以及如何在使效力损失最小化的同时实现最大抑制。此外,通过结合核磁共振(NMR)、分子动力学(MD)模拟和整体变构建模(EAM),我们还展示了如何绘制包含“混合”状态的构象集合的自由能景观。通过讨论选定的案例研究,我们说明了MD模拟和EAM如何补充NMR,以将蛋白质动力学与功能定量关联起来。基于NMR和MD的所得EAMs不仅有望为新一代高选择性变构抑制剂的设计提供信息,也有助于多药组合的选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/a15bf7feb394/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/b01d6d29cb7d/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/f6fce04784b6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/8cb54d0f2655/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/01b119eefa48/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/b8c6e391450f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/2f36436f3932/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/1de7542b50ff/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/ea0d75a76cff/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/1ad76e06f03b/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/69d0fce0c2d9/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/a9739b4c1c9b/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/a15bf7feb394/gr11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/b01d6d29cb7d/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/f6fce04784b6/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/8cb54d0f2655/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/01b119eefa48/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/b8c6e391450f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/2f36436f3932/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/1de7542b50ff/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/ea0d75a76cff/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/1ad76e06f03b/gr8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/69d0fce0c2d9/gr9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/a9739b4c1c9b/gr10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5192/7720024/a15bf7feb394/gr11.jpg

相似文献

1
Allosteric inhibition explained through conformational ensembles sampling distinct "mixed" states.变构抑制通过构象集合对不同“混合”状态的采样来解释。
Comput Struct Biotechnol J. 2020 Nov 11;18:3803-3818. doi: 10.1016/j.csbj.2020.10.026. eCollection 2020.
2
Mechanism of cAMP Partial Agonism in Protein Kinase G (PKG).蛋白激酶G(PKG)中cAMP部分激动作用的机制。
J Biol Chem. 2015 Nov 27;290(48):28631-41. doi: 10.1074/jbc.M115.685305. Epub 2015 Sep 14.
3
Understanding cAMP-dependent allostery by NMR spectroscopy: comparative analysis of the EPAC1 cAMP-binding domain in its apo and cAMP-bound states.通过核磁共振光谱法理解环磷酸腺苷(cAMP)依赖性变构:对处于无配体状态和与cAMP结合状态的EPAC1的cAMP结合结构域进行比较分析。
J Am Chem Soc. 2007 Nov 21;129(46):14482-92. doi: 10.1021/ja0753703. Epub 2007 Oct 31.
4
Detecting Functional Dynamics in Proteins with Comparative Perturbed-Ensembles Analysis.利用比较扰动系综分析检测蛋白质中的功能动力学。
Acc Chem Res. 2019 Dec 17;52(12):3455-3464. doi: 10.1021/acs.accounts.9b00485. Epub 2019 Dec 3.
5
Mechanism of allosteric inhibition in the cGMP-dependent protein kinase.别构抑制在 cGMP 依赖性蛋白激酶中的作用机制。
J Biol Chem. 2020 Jun 19;295(25):8480-8491. doi: 10.1074/jbc.RA120.013070. Epub 2020 Apr 21.
6
cAMP-dependent allostery and dynamics in Epac: an NMR view.cAMP 依赖变构作用和 Epac 的动力学:NMR 观察。
Biochem Soc Trans. 2012 Feb;40(1):219-23. doi: 10.1042/BST20110628.
7
Allosteric pluripotency as revealed by protein kinase A.蛋白激酶 A 揭示的变构多能性
Sci Adv. 2020 Jun 19;6(25):eabb1250. doi: 10.1126/sciadv.abb1250. eCollection 2020 Jun.
8
Non-Canonical Allostery in Cyclic Nucleotide Dependent Kinases.非经典变构作用在环核苷酸依赖激酶中的作用。
J Mol Biol. 2022 Sep 15;434(17):167584. doi: 10.1016/j.jmb.2022.167584. Epub 2022 Apr 12.
9
Allostery and binding cooperativity of the catalytic subunit of protein kinase A by NMR spectroscopy and molecular dynamics simulations.通过 NMR 光谱和分子动力学模拟研究蛋白激酶 A 催化亚基的变构和结合协同性。
Adv Protein Chem Struct Biol. 2012;87:363-89. doi: 10.1016/B978-0-12-398312-1.00012-3.
10
Allosteric pluripotency: challenges and opportunities.变构多能性:挑战与机遇。
Biochem J. 2022 Apr 14;479(7):825-838. doi: 10.1042/BCJ20210528.

引用本文的文献

1
The Ensemble Basis of Allostery and Function: Insights from Models of Local Unfolding.变构与功能的整合基础:局部去折叠模型的见解
J Mol Biol. 2025 Jun 9:169287. doi: 10.1016/j.jmb.2025.169287.
2
Allosteric modulation of NF1 GAP: Differential distributions of catalytically competent populations in loss-of-function and gain-of-function mutants.神经纤维瘤蛋白1(NF1)GAP的变构调节:功能丧失和功能获得突变体中具有催化活性群体的差异分布。
Protein Sci. 2025 Feb;34(2):e70042. doi: 10.1002/pro.70042.
3
Purine nucleosides replace cAMP in allosteric regulation of PKA in trypanosomatid pathogens.

本文引用的文献

1
Conformational states dynamically populated by a kinase determine its function.构象状态由激酶动态填充,决定其功能。
Science. 2020 Oct 9;370(6513). doi: 10.1126/science.abc2754. Epub 2020 Oct 1.
2
Allosteric Mechanisms of Nonadditive Substituent Contributions to Protein-Ligand Binding.非加和取代基对蛋白质-配体结合作用的变构机制
Biophys J. 2020 Sep 15;119(6):1135-1146. doi: 10.1016/j.bpj.2020.07.038. Epub 2020 Aug 15.
3
Allosteric pluripotency as revealed by protein kinase A.蛋白激酶 A 揭示的变构多能性
嘌呤核苷替代 cAMP 在粘体动物病原体蛋白激酶 A 的变构调节中。
Elife. 2024 Mar 22;12:RP91040. doi: 10.7554/eLife.91040.
4
Protein conformational ensembles in function: roles and mechanisms.发挥功能的蛋白质构象集合:作用与机制
RSC Chem Biol. 2023 Sep 5;4(11):850-864. doi: 10.1039/d3cb00114h. eCollection 2023 Nov 1.
5
Mechanistic Elucidation of Activation/Deactivation Signal Transduction within Neurotensin Receptor 1 Triggered by 'Driver Chemical Groups' of Modulators: A Comparative Molecular Dynamics Simulation.调节剂“驱动化学基团”触发的神经降压素受体1内激活/失活信号转导的机制阐释:比较分子动力学模拟
Pharmaceutics. 2023 Jul 21;15(7):2000. doi: 10.3390/pharmaceutics15072000.
6
Allosteric regulation of autoinhibition and activation of c-Abl.c-Abl自抑制与激活的变构调节
Comput Struct Biotechnol J. 2022 Aug 11;20:4257-4270. doi: 10.1016/j.csbj.2022.08.014. eCollection 2022.
7
Understanding gilteritinib resistance to FLT3-F691L mutation through an integrated computational strategy.通过综合计算策略了解 gilteritinib 对 FLT3-F691L 突变的耐药性。
J Mol Model. 2022 Aug 6;28(9):247. doi: 10.1007/s00894-022-05254-0.
8
Identification of core allosteric sites through temperature- and nucleus-invariant chemical shift covariance.通过温度和核不变化学位移协变鉴定核心变构位点。
Biophys J. 2022 Jun 7;121(11):2035-2045. doi: 10.1016/j.bpj.2022.05.004. Epub 2022 May 10.
9
Autopromotion of K-Ras4B Feedback Activation Through an SOS-Mediated Long-Range Allosteric Effect.通过SOS介导的长程变构效应实现K-Ras4B反馈激活的自促进作用。
Front Mol Biosci. 2022 Apr 8;9:860962. doi: 10.3389/fmolb.2022.860962. eCollection 2022.
10
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.变构作用:变构致癌驱动因子和创新变构药物。
J Mol Biol. 2022 Sep 15;434(17):167569. doi: 10.1016/j.jmb.2022.167569. Epub 2022 Apr 1.
Sci Adv. 2020 Jun 19;6(25):eabb1250. doi: 10.1126/sciadv.abb1250. eCollection 2020 Jun.
4
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.分子伴侣TRAP1变构及选择性抑制剂的合理设计
Cell Rep. 2020 Apr 21;31(3):107531. doi: 10.1016/j.celrep.2020.107531.
5
Mechanism of allosteric inhibition in the cGMP-dependent protein kinase.别构抑制在 cGMP 依赖性蛋白激酶中的作用机制。
J Biol Chem. 2020 Jun 19;295(25):8480-8491. doi: 10.1074/jbc.RA120.013070. Epub 2020 Apr 21.
6
Mechanism of Action of an EPAC1-Selective Competitive Partial Agonist.EPAC1 选择性竞争部分激动剂的作用机制。
J Med Chem. 2020 May 14;63(9):4762-4775. doi: 10.1021/acs.jmedchem.9b02151. Epub 2020 Apr 16.
7
Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.癌蛋白错误折叠的化学干预:从局部不稳定结构预测到热休克蛋白 90-客户相互作用抑制剂的设计。
Chemistry. 2020 Aug 3;26(43):9459-9465. doi: 10.1002/chem.202000615. Epub 2020 Jul 8.
8
An allosteric switch regulates ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR.变构开关调节 ClpP1P2 蛋白酶的功能,这一点通过冷冻电镜和甲基-TROSY NMR 得到了证实。
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):5895-5906. doi: 10.1073/pnas.1921630117. Epub 2020 Mar 2.
9
Allosteric drugs and mutations: chances, challenges, and necessity.变构药物与突变:机遇、挑战与必要性。
Curr Opin Struct Biol. 2020 Jun;62:149-157. doi: 10.1016/j.sbi.2020.01.010. Epub 2020 Feb 12.
10
Integrated Computational Approaches and Tools forAllosteric Drug Discovery.变构药物发现的综合计算方法和工具。
Int J Mol Sci. 2020 Jan 28;21(3):847. doi: 10.3390/ijms21030847.